• 1. Discrete and polymeric Cu(ii) complexes featuring substituted indazole ligands: their synthesis and structural chemistry
  Chris S. Hawes,Paul E. Kruger Dalton Trans. 2014 43 16450

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzopyrazoles Indazoles

Exploring the Versatile Applications and Properties of 1H-Indazole-6-carboxylic acid (CAS No. 704-91-6)

The chemical compound 1H-Indazole-6-carboxylic acid (CAS No. 704-91-6) has garnered significant attention in pharmaceutical and biochemical research due to its unique structural properties and potential applications. As a derivative of the indazole family, this compound features a carboxylic acid functional group at the 6-position, making it a valuable intermediate in drug discovery and organic synthesis. Researchers are particularly interested in its role as a building block for heterocyclic compounds, which are crucial in developing new therapeutic agents.

Recent studies highlight the growing demand for 1H-Indazole-6-carboxylic acid derivatives in medicinal chemistry. The compound's molecular framework allows for diverse modifications, enabling scientists to explore its potential in targeting various biological pathways. With the rise of personalized medicine and targeted drug delivery systems, this chemical has become a focal point for innovation in treating complex diseases. Its compatibility with modern green chemistry principles also makes it an attractive candidate for sustainable pharmaceutical development.

The synthesis and characterization of 704-91-6 have been extensively documented in scientific literature. Advanced techniques such as NMR spectroscopy and mass spectrometry confirm its high purity and stability under various conditions. These properties are particularly valuable for researchers working on high-throughput screening and combinatorial chemistry approaches, where reliable building blocks are essential for efficient drug discovery pipelines.

In the context of current market trends, the global demand for indazole-based compounds continues to rise, driven by their applications in developing kinase inhibitors and GPCR modulators. Pharmaceutical companies are increasingly investing in research involving 1H-Indazole-6-carboxylic acid scaffolds as potential treatments for inflammatory disorders and metabolic diseases. This aligns with the growing focus on precision medicine and the need for more specific therapeutic agents with fewer side effects.

From a technical perspective, the physical and chemical properties of 1H-Indazole-6-carboxylic acid make it suitable for various synthetic applications. Its moderate solubility in polar organic solvents and characteristic melting point range facilitate its use in multi-step organic synthesis. The compound's stability under ambient conditions also contributes to its popularity as a research chemical in academic and industrial laboratories worldwide.

The future prospects for CAS 704-91-6 appear promising, with ongoing research exploring its potential in novel drug formulations and biochemical probes. As the scientific community continues to unravel the full potential of indazole derivatives, this particular compound is expected to play an increasingly important role in advancing pharmaceutical innovation and addressing unmet medical needs through rational drug design approaches.

• 61700-61-6(1H-Indazole-5-carboxylic Acid)
• 1263378-95-5(4-Methyl-1H-indazole-6-carboxylic acid)
• 90770-91-5(4-methyl-7-Cinnolinecarboxylic acid)
• 170487-40-8(Methyl 1h-indazole-6-carboxylate)
• 677306-38-6(1H-Indazole-4-carboxylic Acid)
• 561700-61-6(1h-indazole-5-carboxylic Acid)
• 1031417-41-0(7-Methyl-1H-indazole-5-carboxylic acid)
• 1263378-71-7(Methyl 4-methyl-1H-indazole-6-carboxylate)
• 20684-46-2(Benzo[c]cinnoline-2-carboxylic acid)
• 915139-44-5(1H-indazole-5-carboxylic acid;hydrochloride)